Selective modulation of neutrophils in critical illness
危重疾病中中性粒细胞的选择性调节
基本信息
- 批准号:9750019
- 负责人:
- 金额:$ 40.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-05 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressBacterial InfectionsBiologicalBiologyBlood CirculationCRISPR/Cas technologyCoupledCritical IllnessDiseaseGeneticGenetic ScreeningGoalsHealthHemorrhagic ShockHospitalsHost DefenseHumanImmuneImmune System DiseasesImmune systemImmunityInfectionInjuryIntegrinsKnowledgeLeukocytesLifeLiquid substanceLungMediatingModelingModificationMolecularNatureNeutrophil InfiltrationOperative Surgical ProceduresOrganismPhagocytosisPhenotypePlasmaPredispositionResearchRespiratory Tract InfectionsRoleSecondary toShockTissuesTraumaTrauma patientTraumatic injuryWorkantimicrobialcytotoxicfightinginnovationmortalitymouse modelneutrophilpathogenic bacteriapathogenic fungusprogramsrecruitresponsesecondary infection
项目摘要
Abstract
Critical illness describes the life-threatening state caused by immune dysfunction that can occur
following traumatic injury, shock, burn or major surgery. Trauma-induced immune incompetence enhances
susceptibility to secondary infections that are a significant cause of mortality in hospital ICUs. Neutrophils, the
most abundant leukocyte in the circulation, are critical for host defense against bacterial and fungal pathogens,
but they also induce bystander tissue injury due to the non-specific and cytotoxic nature of their antimicrobial
arsenal. The effects of trauma on neutrophils contribute to immune dysfunction and include a significant deficit
in neutrophil capacity to find and fight infection, coupled with a primed phenotype associated with inducing
tissue damage. The long-term goals of my research program are to understand mechanisms of neutrophil
recruitment and effector function in health and disease. This MIRA application describes our synergistic
approaches to identifying and understanding mechanisms of neutrophil pathobiology during critical illness.
First, we have established an innovative approach to derive neutrophils ex vivo that circumvents the technical
barriers to their genetic modification. This enables us to perform multiplexed forward genetic screening using
CRISPR-Cas9 in neutrophils, and thereby identify new mechanistic aspects of their recruitment (e.g., integrin
activation) and antimicrobial function (e.g., phagocytosis). Second, we have established a mouse model of
critical illness by respiratory infection secondary to hemorrhagic shock. As the lungs are particularly
susceptible to infection secondary to trauma and are also prone to neutrophil-mediated injury, this model
provides a means to evaluate new targets/strategies for promoting selective aspects of neutrophil function to
enhance host defense without exacerbating tissue damage. Finally, we will apply human trauma patient
material (blood, plasma, lung fluid) to these approaches to probe disease-specific mechanisms of the
neutrophil response. Since our studies will interrogate fundamental biological mechanisms, such as integrin
activation, this work will also have broad impact on multiple fields. Together, these integrated approaches will
address major knowledge gaps in neutrophil biology by spanning the molecular, cellular and organism/disease
levels of experimentation.
抽象的
危害疾病描述了可能发生的免疫功能障碍引起的威胁生命的状态
创伤性损伤,休克,烧伤或大型手术后。创伤引起的免疫无能增强
对继发感染的敏感性,这是医院ICU死亡的重要原因。中性粒细胞,
循环中最丰富的白细胞对于宿主防御细菌和真菌病原体至关重要,
但是,由于其抗菌剂的非特异性和细胞毒性性质,它们还会诱导旁观者组织损伤
兵工厂。创伤对中性粒细胞的影响有助于免疫功能障碍,并包括明显的赤字
嗜中性粒细胞能够找到和抗击感染,再加上与诱导的底漆表型
组织损伤。我的研究计划的长期目标是了解中性粒细胞的机制
健康和疾病中的招聘和效应子功能。此MIRA应用描述了我们的协同作用
识别和理解危害疾病期间嗜中性粒细胞病理学机制的方法。
首先,我们已经建立了一种创新的方法来得出嗜中性粒细胞,从而绕过技术
其遗传修饰的障碍。这使我们能够使用
中性粒细胞中的CRISPR-Cas9,从而确定其招募的新机械方面(例如,整合素
激活)和抗菌功能(例如吞噬作用)。其次,我们建立了一个鼠标模型
呼吸道感染因出血性休克而受到疾病。因为肺部特别
易受创伤继发的感染,也容易受到中性粒细胞介导的损伤,该模型
提供了一种评估新目标/策略的方法,以促进中性粒细胞功能的选择性方面
增强宿主防御,而不会加剧组织损伤。最后,我们将应用人类创伤患者
材料(血液,血浆,肺液),用于探测疾病特异性机制的方法
中性粒细胞反应。由于我们的研究将询问基本生物学机制,例如整合素
激活,这项工作还将对多个领域产生广泛的影响。这些综合方法将在一起
通过跨越分子,细胞和生物/疾病来解决中性粒细胞生物学的主要知识差距
实验水平。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRAIG THOMAS LEFORT其他文献
CRAIG THOMAS LEFORT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRAIG THOMAS LEFORT', 18)}}的其他基金
56th Annual Meeting of the Society for Leukocyte Biology
白细胞生物学学会第 56 届年会
- 批准号:
10752090 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别:
Selective Modulation of Neutrophils in Critical Illness
危重疾病中中性粒细胞的选择性调节
- 批准号:
10551956 - 财政年份:2017
- 资助金额:
$ 40.25万 - 项目类别:
A murine model of Pseudomonas aeruginosa pneumonia secondary to hemorrhagic shock
失血性休克继发铜绿假单胞菌肺炎小鼠模型
- 批准号:
9294349 - 财政年份:2017
- 资助金额:
$ 40.25万 - 项目类别:
Selective modulation of neutrophils in critical illness
危重疾病中中性粒细胞的选择性调节
- 批准号:
9382234 - 财政年份:2017
- 资助金额:
$ 40.25万 - 项目类别:
Selective modulation of neutrophils in critical illness
危重疾病中中性粒细胞的选择性调节
- 批准号:
10220991 - 财政年份:2017
- 资助金额:
$ 40.25万 - 项目类别:
相似国自然基金
智能响应细菌生物膜微环境的GQDs/Mn:ZnSe纳米复合水凝胶构筑及用于感染诊疗一体化研究
- 批准号:22305098
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于乏氧增强型超声抗菌剂的细菌生物膜感染协同治疗研究
- 批准号:22375101
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
靶向细菌感染部位的两栖类皮肤抗菌肽类似物的构建、酶促自组装性能及生物活性研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
靶向细菌感染部位的两栖类皮肤抗菌肽类似物的构建、酶促自组装性能及生物活性研究
- 批准号:32270513
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
细菌吞噬纳米探针实现增强生物发光成像及治疗深部组织细菌感染的研究
- 批准号:22204117
- 批准年份:2022
- 资助金额:20 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
- 批准号:
10549648 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别:
Project 2: Ex Vivo Modeling and Analysis of Gastric Precancerous Lesions
项目2:胃癌前病变的离体建模与分析
- 批准号:
10715763 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别:
Novel single-cell mass spectrometry methods to assess the role of intracellular drug concentration and metabolism in antimicrobial treatment failure
评估细胞内药物浓度和代谢在抗菌治疗失败中的作用的新型单细胞质谱方法
- 批准号:
10714351 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别:
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
针对创伤引起的免疫失调中训练有素的免疫力
- 批准号:
10714384 - 财政年份:2023
- 资助金额:
$ 40.25万 - 项目类别: